Ischemic Stroke: New Neuron Recovery Approach with Mesenchymal and Neural Stem Cells
Abstract
Stroke is a leading cause of death and long-term disability. This due to the ischemic event that cause by embolism of blockage blood flow. Thrombolytic agent plasminogen activator (tPA) is the only treatment approved by FDA. However, the used of tPA is limited to the short time window period. Neural stem cells (NSCs) show the potential to repair neuronal damage naturally after stroke. However, isolating NSCs is a challenging process due to the limitations of the method and its invasiveness. Some studies that had used mesenchymal stem cell (MSCs) as the main source of stem cell for therapy show that MSCs have the potency to differentiate into NSCs. in vitro, a differentiation process from MSC to NSC has been developed by combining the supplement or growth factor needed in the culture media.
Keywords: stem cells, neuron stem cell, mesenchymal stem cell, stroke, trans-differentiation
Full Text:
PDFReferences
Stapf C, Mohr JP. Ischemic Stroke Therapy. Annu Rev Med. 2002; 53: 453-75, CrossRef.
Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early Stroke Treatment Associated with Better Outcome: The NINDS rt-PA Stroke Study. Neurology. 2000; 55(11): 1649-55, CrossRef.
Corey S, Ghanekar S, Sokol J, Zhang JH, Borlongan CV. An Update on Stem Cell Therapy for Neurological Disorders: Cell Death Pathways as Therapeutic Targets. Chin Neurosurg J. 2017; 3: 4, CrossRef.
Li G, Yu F, Lei T, Gao H, Li P, Sun Y, et al. Bone Marrow Mesenchymal Stem Cell Therapy in Ischemic Stroke: Mechanisms of Action and Treatment Optimization Strategies. Neural Regen Res. 2016; 11(6): 1015-24, CrossRef.
Sart S, Ma T, Li Y. Preconditioning Stem Cells for In Vivo Delivery. BioResearch. 2014; 3(4): 137-49, CrossRef.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart Disease and Stroke Statistics--2015 Update: A Report from the American Heart Association. Circulation. 2015; 131(4): e29-322, CrossRef.
Yudiarto F, Machfoed M, Darwin A, Ong A, Karyana M, Siswanto. Indonesia Stroke Registry (S12.003). Neurology. 2014; 82(Suppl10): S12.003, article.
Levy YS, Stroomza M, Melamed E, Offen D. Embryonic and Adult Stem Cells as A Source for Cell Therapy in Parkinson’s Disease. J Mol Neurosci. 2004; 24(3): 353-86, CrossRef.
Damayanti S, Triana R, Chouw A, Dewi NM. Is Stem Cell a Curer or an Obstruction? Mol Cell Biomed Sci. 2017; 1(1): 17-27, CrossRef.
Xu W, Zheng J, Gao L, Li T, Zhang J, Shao A. Neuroprotective Effects of Stem Cells in Ischemic Stroke. Stem Cells Int. 2017; 2017: 4653936, CrossRef.
Bang OY, Kim EH, Cha JM, Moon GJ. Adult Stem Cell Therapy for Stroke: Challenges and Progress. J Stroke. 2016; 18(3): 256-66, CrossRef.
Hsuan YCY, Lin CH, Chang CP, Lin MT. Mesenchymal Stem Cell-based Treatments for Stroke, Neural Trauma, and Heat Stroke. Brain Behav. 2016; 6(10): e00526, CrossRef.
Daadi MM, Steinberg GK. Manufacturing Neurons from Human Embryonic Stem Cells: Biological and Regulatory Aspects to Develop a Safe Cellular Product for Stroke Cell Therapy. Regen Med. 2009; 4(2): 251-63, CrossRef.
Meamar R, Dehghani L, Ghasemi M, Khorvash F, Shaygannejad V. Stem Cell Therapy in Stroke: A Review Literature. Int J Prev Med. 2013; 4(Suppl 2): S139-46, PMID.
Gonzalez MA, Bernad A. Characteristics of Adult Stem Cells. Adv Exp Med Biol. 2012; 741: 103-20, CrossRef.
Maria Ferri AL, Bersano A, Lisini D, Boncoraglio G, Frigerio S, Parati E. Mesenchymal Stem Cells for Ischemic Stroke: Progress and Possibilities. Curr Med Chem. 2016; 23(16): 1598-608, CrossRef.
Anderson JD, Pham MT, Contreras Z, Hoon M, Fink KD, Johansson HJ, et al. Mesenchymal Stem Cell-based Therapy for Ischemic Stroke. Chin Neurosurg J. 2016; 2(1): 36, CrossRef.
Glenn JD, Whartenby KA. Mesenchymal Stem Cells: Emerging Mechanisms of Immunomodulation and Therapy. World J Stem Cells. 2014; 6(5): 526-39, CrossRef.
Seo JH, Cho SR. Neurorestoration Induced by Mesenchymal Stem Cells: Potential Therapeutic Mechanisms for Clinical Trials. Yonsei Med J. 2012; 53(6): 1059-67, CrossRef.
Aggarwal S, Pittenger MF. Human Mesenchymal Stem Cells Modulate Allogeneic Immune Cell Responses. Blood. 2005; 105(4): 1815-22, CrossRef.
Toyoshima A, Yasuhara T, Date I. Mesenchymal Stem Cell Therapy for Ischemic Stroke. Acta Med Okayama. 2017; 71(4): 263-8, CrossRef.
Ikegame Y. Among Mesenchymal Stem Cells: for the Best Therapy After Ischemic Stroke. Stem Cell Res Ther. 2013; 4(1): 9, CrossRef.
Yu Q, Liu L, Lin J, Wang Y, Xuan X, Guo Y, et al. SDF-1α/CXCR4 Axis Mediates The Migration of Mesenchymal Stem Cells to The Hypoxic-Ischemic Brain Lesion in A Rat Model. Cell J Yakhteh. 2015; 16(4): 440-7, CrossRef.
Sullivan R, Duncan K, Dailey T, Kaneko Y, Tajiri N, Borlongan CV. A Possible New Focus for Stroke Treatment – Migrating Stem Cells. Expert Opin Biol Ther. 2015; 15: 949-58, CrossRef.
Cencioni C, Capogrossi MC, Napolitano M. The SDF-1/CXCR4 Axis in Stem Cell Preconditioning. Cardiovasc Res. 2012; 94(3): 400-7, CrossRef.
Tate CC, Fonck C, McGrogan M, Case CC. Human Mesenchymal Stromal Cells and their Derivative, SB623 Cells, Rescue Neural Cells via Trophic Support following in Vitro Ischemia Human Mesenchymal Stromal Cells and their Derivative, SB623 Cells, Rescue Neural Cells via Trophic Support following in Vitro Ischemia. Cell Transplant. 2010; 19(8): 973-84, CrossRef.
Collawn SS, Patel S. Adipose-Derived Stem Cells, their Secretome, and Wound Healing. J Cell Sci Ther. 2014; 5(3): 165, CrossRef.
Martínez-Garza DM, Cantú-Rodríguez OG, Jaime-Pérez JC, Gutiérrez-Aguirre CH, Góngora-Rivera JF, Gómez-Almaguer D. Current State and Perspectives of Stem Cell Therapy for Stroke. Med Univ. 2016; 18(72): 169-80, CrossRef.
Magnon C, Lucas D, Frenette PS. Trafficking of Stem Cells. In: Filippi MD, Geiger H. Stem Cell Migration. New York: Humana Press; 2011. p.3-24, CrossRef.
Cruz JO-D la, Ayuso-Sacido A. Neural Stem Cells from Mammalian Brain: Isolation Protocols and Maintenance Conditions. In: Neural Stem Cells and Therapy. London: IntechOpen; 2012. p.1-29, CrossRef.
Arien-Zakay H, Lecht S, Nagler A, Lazarovici P. Human Umbilical Cord Blood Stem Cells: Rational for Use as a Neuroprotectant in Ischemic Brain Disease. Int J Mol Sci. 20101; (19): 3513-28, CrossRef.
Yoshida N, Hishiyama S, Yamaguchi M, Hashiguchi M, Miyamoto Y, Kaminogawa S, et al. Decrease in Expression of Alpha 5 Beta 1 Integrin during Neuronal Differentiation of Cortical Progenitor Cells. Exp Cell Res. 2003; 287(2): 262-71, CrossRef.
Maric D, Maric I, Chang YH, Barker JL. Prospective Cell Sorting of Embryonic Rat Neural Stem Cells and Neuronal and Glial Progenitors Reveals Selective Effects of Basic Fibroblast Growth Factor and Epidermal Growth Factor on Self-renewal and Differentiation. J Neurosci Off J Soc Neurosci. 2003; 23(1): 240-51, CrossRef.
Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, Jiang L, et al. Identification and Isolation of Multipotential Neural Progenitor Cells from the Subcortical White Matter of the Adult Human Brain. Nat Med. 2003; 9(4): 439-47, CrossRef.
Windrem MS, Roy NS, Wang J, Nunes M, Benraiss A, Goodman R, et al. Progenitor Cells Derived from the Adult Human Subcortical White Matter Disperse and Differentiate as Oligodendrocytes Within Demyelinated Lesions of the Rat Brain. J Neurosci Res. 2002; 69(6): 966-75, CrossRef.
Wright AP, Fitzgerald JJ, Colello RJ. Rapid Purification of Glial Cells Using Immunomagnetic Separation. J Neurosci Methods. 1997; 74(1): 37-44, CrossRef.
Panchision DM, Chen H-L, Pistollato F, Papini D, Ni H-T, Hawley TS. Optimized Flow Cytometric Analysis of Central Nervous System Tissue Reveals Novel Functional Relationships among Cells Expressing CD133, CD15, and CD24. Stem Cells Dayt Ohio. 2007; 25(6): 1560-70, CrossRef.
Capela A, Temple S. LeX/ssea-1 is Expressed by Adult Mouse CNS Stem Cells, Identifying Them as Nonependymal. Neuron. 2002; 35(5): 865-75, CrossRef.
Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Fortunato F, et al. Multipotentiality, Homing Properties, and Pyramidal Neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ Stem Cells. FASEB J Off Publ Fed Am Soc Exp Biol. 2005; 19(13): 1860-2, CrossRef.
Liu Y, Han SSW, Wu Y, Tuohy TMF, Xue H, Cai J, et al. CD44 Expression Identifies Astrocyte-restricted Precursor Cells. Dev Biol. 2004; 276(1): 31-46, CrossRef.
Siebzehnrubl FA, Vedam-Mai V, Azari H, Reynolds BA, Deleyrolle LP. Isolation and Characterization of Adult Neural Stem Cells. Methods Mol Biol Clifton. 2011; 750: 61-77, CrossRef.
Murayama A, Matsuzaki Y, Kawaguchi A, Shimazaki T, Okano H. Flow Cytometric Analysis of Neural Stem Cells in the Developing and Adult Mouse Brain. J Neurosci Res. 2002; 69(6): 837-47, CrossRef.
Rietze RL, Valcanis H, Brooker GF, Thomas T, Voss AK, Bartlett PF. Purification of A Pluripotent Neural Stem Cell from the Adult Mouse Brain. Nature. 2001; 412(6848): 736-9, CrossRef.
Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct Isolation of Human Central Nervous System Stem Cells. Proc Natl Acad Sci USA. 2000; 97(26): 14720-5, CrossRef.
Aguirre AA, Chittajallu R, Belachew S, Gallo V. NG2-expressing Cells in the Subventricular Zone are Type C–like Cells and Contribute to Interneuron Generation in the Postnatal Hippocampus. J Cell Biol. 2004; 165(4): 575-89, CrossRef.
Duncan ID, Paino C, Archer DR, Wood PM. Functional Capacities of Transplanted Cell-Sorted Adult Oligodendrocytes. Dev Neurosci. 1992; 14(2): 114-22, CrossRef.
Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisén J. Identification of A Neural Stem Cell in the Adult Mammalian Central Nervous System. Cell. 1999; 96(1): 25-34, CrossRef.
Ciccolini F, Mandl C, Hölzl-Wenig G, Kehlenbach A, Hellwig A. Prospective Isolation of Late Development Multipotent Precursors Whose Migration is Promoted by EGFR. Dev Biol. 2005; 284(1): 112-25, CrossRef.
Pastrana E, Cheng LC, Doetsch F. Simultaneous Prospective Purification of Adult Subventricular Zone Neural Stem Cells and Their Progeny. Proc Natl Acad Sci USA. 2009; 106(15): 6387-92, CrossRef.
Drago D, Cossetti C, Iraci N, Gaude E, Musco G, Bachi A, et al. The Stem Cell Secretome and Its Role in Brain Repair. Biochimie. 2013; 95(12): 2271-85, CrossRef.
Ghasemi N, Razavi S. Transdifferentiation Potential of Adiposederived Stem Cells into Neural Lineage and Their Application. J Histol Histopathol. 2014; 1(1): 12, CrossRef.
Krabbe C, Zimmer J, Meyer M. Neural Transdifferentiation of Mesenchymal Stem Cells – A Critical Review. APMIS. 2005;113(11–12): 831-44, CrossRef.
Mareschi K, Novara M, Rustichelli D, Ferrero I, Guido D, Carbone E, et al. Neural Differentiation of Human Mesenchymal Stem Cells: Evidence for Expression of Neural Markers and Eag K+ Channel Types. Exp Hematol. 2006; 34(1 1): 1563-72, CrossRef.
Shahbazi A, Safa M, Alikarami F, Kargozar S, Asadi MH, Joghataei MT, et al. Rapid Induction of Neural Differentiation in Human Umbilical Cord Matrix Mesenchymal Stem Cells by cAMPelevating Agents. Int J Mol Cell Med. 2016; 5(3): 167-77, PMID.
Moore TJ, Abrahamse H. Neuronal Differentiation of Adipose Derived Stem Cells: Progress So Far. Int J Photoenergy. 2014; 2014: e827540, CrossRef.
Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult Rat and Human Bone Marrow Stromal Cells Differentiate into Neurons. J Neurosci Res. 2000; 61(4): 364-70, CrossRef.
Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, et al. Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro. Exp Neurol. 2000; 164(2): 247-56, CrossRef.
Misra V, Ritchie MM, Stone LL, Low WC, Janardhan V. Stem Cell Therapy in Ischemic Stroke. Neurology. 2012; 79(13 Suppl 1): S207-12, CrossRef.
Andres RH, Choi R, Steinberg GK, Guzman R. Potential of Adult Neural Stem Cells in Stroke Therapy. Regen Med. 2008; 3(6): 893-905, CrossRef.
Baraniak PR, McDevitt TC. Stem Cell Paracrine Actions and Tissue Regeneration. Regen Med. 2010; 5(1): 121-43, CrossRef.
DOI: https://doi.org/10.21705/mcbs.v2i2.28
Copyright (c) 2018 Cell and BioPharmaceutical Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
Cell and BioPharmaceutical Institute
